Tuesday, November 24, 2009

The Leibniz Institute for Age Research - Fritz Lipmann Institute (FLI) in Jena, Germany invites applications

The Leibniz Institute for Age Research - Fritz Lipmann Institute (FLI)
in Jena, Germany invites applications for:

PhD positions (code number 2609)

to work in projects of the 3 year research program LeibnizAgeNet:
Signalling Pathways in Diseases of Ageing. All projects will employ
genome-scale loss-of-function analysis in cultured cells, following
RNA interference. The positions are part of the Leibniz Graduate
School on Ageing and Age-Related Diseases (LGSA)

Experience with one or more of the following would be advantageous:
high-throughput and RNAi techniques, HCS microscopy functional assays,
automated liquid handling systems, bioinformatics analysis, database
handling. Fluency in spoken and written english plus very good working
knowledge of standard computer operating systems and software are
essential.

Starting date is January 2010. The contract conditions and the salary
will be according to the collective labour agreement for public
service employees of the federal states of Germany (TV-L E13 /2).

PhD candidate applications, citing the code number 2609, should be
submitted tolgsa@fli-leibniz.de, according to the application
guidelines found at http://www.fli-leibniz.de/phd/

The deadline for application submission is 22nd November 2009.
Interviews are planned for the 1st week of December.

Further information can be obtained by contacting:
Drs. A. Ploubidou (ploubidou@fli-leibniz.de) and H. Morrison (helen@fli-leibniz.de)

(Analysis of cytoskeleton-mediated signal transduction)
Dr. C. Kaether (ckaether@fli-leibniz.de) and Prof. P.Herrlich (pherrlich@fli-leibniz.de)

(Identification of regulators of intramembraneous protein cleavage)
Dr. J. Tuckermann (j.tuckermann@fli-leibniz.de)
(Inhibition of stromal cell - induced tumour growth)
Please see also http://www.fli-leibniz.de/index_en.php



Homepage: http://www.fli-leibniz.de/phd/

[cross-posting: MOLDOVAdoc].

No comments:

Post a Comment